Literature DB >> 30988907

Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance.

Norah A Terrault1, Anna S F Lok2, Brian J McMahon3, Kyong-Mi Chang4, Jessica P Hwang5, Maureen M Jonas6, Robert S Brown7, Natalie H Bzowej8, John B Wong9.   

Abstract

Entities:  

Year:  2018        PMID： 30988907      PMCID： PMC6385899          DOI： 10.1002/cld.728

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  47 in total

Review 1.  Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.

Authors:  Nicole D Ferrante; Vincent Lo Re
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

Review 2.  Regional Program to Reduce Liver Cancer Associated With Viral Hepatitis B: Comprehensive Approach Corroborating With the Media and Regional Government to Improve Population Screening Rate in Saga Prefecture.

Authors:  Yuichiro Eguchi; Hiroshi Isoda; Hirokazu Takahashi
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

Review 3.  Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies.

Authors:  Danielle J Smalls; Reagan E Kiger; LeAnn B Norris; Charles L Bennett; Bryan L Love
Journal:  Pharmacotherapy       Date:  2019-11-03       Impact factor: 4.705

4.  Switching from Tenofovir-Based Combination Therapy to Tenofovir Monotherapy in Multidrug-Experienced Chronic Hepatitis B Patients: a 5-Year Experience at Two Centers.

Authors:  Jung Hun Kim; Jeong Han Kim; Won Hyeok Choe; So Young Kwon; Byung-Chul Yoo; Eileen L Yoon; Seong Hee Kang
Journal:  Antimicrob Agents Chemother       Date:  2022-07-13       Impact factor: 5.938

5.  Magnetic resonance quantitative susceptibility mapping in the evaluation of hepatic fibrosis in chronic liver disease: a feasibility study.

Authors:  Zheng Qu; Shuohui Yang; Feng Xing; Rui Tong; Chenyao Yang; Rongfang Guo; Jiling Huang; Fang Lu; Caixia Fu; Xu Yan; Stefanie Hectors; Kelly Gillen; Yi Wang; Chenghai Liu; Songhua Zhan; Jianqi Li
Journal:  Quant Imaging Med Surg       Date:  2021-04

6.  Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.

Authors:  E Seremba; P Ocama; R Ssekitoleko; H Mayanja-Kizza; S V Adams; J Orem; E Katabira; S J Reynolds; R Nabatanzi; C Casper; W Phipps
Journal:  Vaccine       Date:  2021-01-28       Impact factor: 3.641

7.  Brazilian Protocol for Sexually Transmitted Infections 2020: viral hepatitis.

Authors:  Geraldo Duarte; Paula Pezzuto; Tiago Dahrug Barros; Gláucio Mosimann Junior; Flor Ernestina Martinez-Espinosa
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

Review 8.  HBV Reactivation During the Treatment of Non-Hodgkin Lymphoma and Management Strategies.

Authors:  Xing Cao; Yafei Wang; Panyun Li; Wei Huang; Xiaojuan Lu; Hongda Lu
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

Review 9.  Current impact of viral hepatitis on liver cancer development: The challenge remains.

Authors:  Ângelo Zambam de Mattos; Jose D Debes; Andre Boonstra; Ju-Dong Yang; Domingo C Balderramo; Giovana D P Sartori; Angelo Alves de Mattos
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

10.  Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis.

Authors:  Xuefeng Ma; Shousheng Liu; Mengke Wang; Yifen Wang; Shuixian Du; Yongning Xin; Shiying Xuan
Journal:  J Clin Transl Hepatol       Date:  2021-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.